A double-blind, randomized, placebo- and positive-controlled phase III trial of 1% benvitimod cream in mild-to-moderate plaque psoriasis

BACKGROUND: Benvitimod cream, a novel synthetic small molecule, was effective in treating mild-to-moderate plaque psoriasis. We conducted a phase III clinical trial to assess the efficacy and safety of benvitimod cream in patients with mild-to-moderate plaque psoriasis. METHODS: We randomly assigned...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Lin, Chen, Gen-Hui, Lu, Qian-Jin, Zheng, Min, Li, Yu-Zhen, Chen, Jin, Zheng, Jie, Zhang, Fu-Ren, Yu, Jian-Bin, Yang, Sen, Li, Fu-Qiu, Xiao, Sheng-Xiang, Sun, Qiu-Ning, Xu, Jin-Hua, Gao, Xing-Hua, Fang, Hong, Gao, Tian-Wen, Hao, Fei, Liu, Quan-Zhong, Tu, Ya-Ting, Li, Ruo-Yu, Wang, Bao-Xi, Deng, Dan-Qi, Zheng, Qing-Shan, Liu, Hong-Xia, Zhang, Jian-Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752683/
https://www.ncbi.nlm.nih.gov/pubmed/33177393
http://dx.doi.org/10.1097/CM9.0000000000001221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752683/
https://www.ncbi.nlm.nih.gov/pubmed/33177393
http://dx.doi.org/10.1097/CM9.0000000000001221

Ejemplares similares